Rani Therapeutics Holdings Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | -2,309.9% | – | – | |
| – | +4.1% | +9.3% | +2.8% | +1.6% | +2.7% | -5.6% | -4.4% | -7.1% | -16.6% | -13.4% | -5.6% | – | |
| – | -9.7% | -13.7% | +6.7% | -2.1% | -1.2% | -1.7% | -16.1% | -28.8% | -4.5% | -6.9% | +16.3% | – | |
| – | – | – | -93.0% | -909.9% | – | – | +4,242.9% | -121.4% | – | -116.1% | – | – | |
| – | -65.1% | -89.2% | +422.2% | +33.0% | -75.2% | +64.5% | -27.5% | -100.0% | – | – | +113.3% | – | |
| – | +13.7% | -22.4% | -36.6% | -92.8% | +437.5% | +623.1% | -68.7% | -102.6% | +20,548.0% | -92.1% | +494.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +200.0% | +0.0% | +0.0% | +0.0% | +152.6% | -100.0% | – | – | |
| – | +95.9% | +26.0% | +16.5% | +5,363.8% | -27.1% | -166.4% | – | -636.7% | – | -100.1% | – | – | |
| – | – | +13.6% | -333.3% | – | – | – | -98.3% | -5,882.9% | – | -163.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | -2,315.0% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.